NEW YORK (GenomeWeb News) — Illumina today sent a third letter to shareholders urging them to turn away Roche's hostile bid for the company. At the same time, Roche expressed disappointment in Illumina's rebuff of its increased offer last week.

Illumina's annual shareholder meeting is scheduled for April 18, during which stockholders will elect four board members and vote on a proposal by Roche to expand the board by two members. Roche has named its own candidates for all open board positions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.